p.158 抽出テキスト

46 Ohgi S, Tachibana M, Ikebuchi M, et al. Pulmonary embolism in

patients with isolated soleal vein thrombosis. Angiology 1998; 49: 759-764. PMID: 9756428 47. Macdonald PS, Kahn SR, Miller N, et al. Short-term natural history of isolated gastrocnemius and soleal vein thrombosis. J Vasc Surg 2003; 37: 523-527. PMID: 12618686 48. Schwarz T, Buschmann L, Beyer J, et al. Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. J Vasc Surg 2010; 52: 1246-1250. PMID: 20630682 49. Palareti G, Cosmi B, Lessiani G, et al. Evolution of untreated calf deep-vein thrombosis in high risk symptomatic outpatients: the blind, prospective CALTHRO study. Thromb Haemost 2010; 104: 1063-1070. PMID: 20694281 50. Prandoni P, Lensing AW, Büller HR, et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992; 327: 1128-1133. PMID: 1528208 51. Gore JM, Appelbaum JS, Greene HL, et al. Occult cancer in patients with acute pulmonary embolism. Ann Intern Med 1982; 96: 556- 560. PMID: 7073147 52. Browse NL, Burnand KG, Irvine AT, et al. Deep vein thrombosis: pathology and diagnosis. In: Browse NL, et al., editors. Diseases of the Veins. Arnold, 1999: 249-291. 53. Wells PS, Hirsh J, Anderson DR, et al. Accuracy of clinical assessment of deep-vein thrombosis. Lancet 1995; 345: 1326-1330. PMID: 7752753 54. Plate G, Ohlin P, Eklöf B. Pulmonary embolism in acute iliofemoral venous thrombosis. Br J Surg 1985; 72: 912-915. PMID: 4063765 55. Nicolaides AN, Breddin HK, Fareed J, et al. Cardiovascular disease educational and research trust and the International Union of Angiology. Prevention of venous thromboembolism. International consensus statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol 2001; 20: 1-37. PMID: 11342993 56. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest 2001; 119 Suppl: 132S-175S. PMID: 11157647 57. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141 Suppl: e195S-e226S. PMID: 22315261 58. Nicolaides AN, Fareed J, Kakkar AK, et al. Prevention and treatment of venous thromboembolism International Consensus Statement. Int Angiol 2013; 32: 111-260. PMID: 24402349 59. Watanabe H, Kodama M, Tanabe N, et al. Impact of earthquakes on risk for pulmonary embolism. Int J Cardiol 2008; 129: 152-154. PMID: 17651831 60. 日本循環器学会,日本高血圧学会,日本心臓病学会.循環器病ガイドシリーズ2014年度版:災害時循環器疾患の予防・管理に関するガイドライン.https://www.j-circ.or.jp/cms/wp-content/ uploads/2020/02/JCS2014_shimokawa_h.pdf 61. Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and cardiovascular disease. Circulation 2020; 141: 1648-1655. PMID: 32200663 62. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 2020; 75: 2352-2371. PMID: 32201335 63. Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18: 844-847. PMID: 32073213 64. Lew TW, Kwek TK, Tai D, et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA 2003; 290: 374-380. PMID: 12865379 65. Mehta P, McAuley DF, Brown M, et al. HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020; 395: 1033-1034. PMID: 32192578 66. Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020; 382: e38. PMID: 32268022 67. Cui S, Chen S, Li X, et al. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 2020; 18: 1421-1424. PMID: 32271988 68. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020; 191: 145-147. PMID: 32291094 69. Nopp S, Moik F, Jilma B, et al. Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis. Res Pract Thromb Haemost 2020; 4: 1178-1191. PMID: 33043231 70. Yamashita Y, Yamada N, Mo M. The primary prevention of venous

thromboembolism in patients with COVID-19 in Japan: Current sta- tus and future perspective. Ann Vasc Dis 2021; 14: 1-4. PMID: 33786092 71. Yamashita Y, Hara N, Obana M, et al. Clinical features of venous

thromboembolism in patients with Coronavirus disease 2019 (COVID-19) in Japan A case series study. Circ J 2021; 85: 309-313. PMID: 33473096 72. Horiuchi H, Morishita E, Urano T, et al. Questionnaire-survey joint team on the COVID-19-related thrombosis. COVID-19-related thrombosis in Japan: Final report of a questionnaire-based survey in 2020. J Atheroscler Thromb 2021; 28: 406-416. PMID: 33678766 73. Yamashita Y, Maruyama Y, Satokawa H, et al. Taskforce of VTE and COVID-19 in Japan Study. Incidence and clinical features of venous thromboembolism in hospitalized patients with Coronavirus disease 2019 (COVID-19) in Japan. Circ J 2021; 85: 2208-2214. PMID: 34011824 74. Nishimoto Y, Yachi S, Takeyama M, et al. CLOT-COVID Study Investigators. The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT- COVID study. J Cardiol 2022; 80: 285-291. PMID: 35430141 75. Schulman S, Sholzberg M, Spyropoulos AC, et al. International Society on Thrombosis and Haemostasis. ISTH guidelines for antithrombotic treatment in COVID-19. J Thromb Haemost 2022; 20: 2214-2225. PMID: 35906716 76. Moores LK, Tritschler T, Brosnahan S, et al. Thromboprophylaxis in patients with COVID-19: A brief update to the CHEST guideline and expert panel report. Chest 2022; 162: 213-225. PMID: 35167861 77. Lopes RD, de Barros E Silva PGM, Furtado RHM, et al. ACTION Coalition COVID-19 Brazil IV Investigators. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial. Lancet 2021; 397: 2253-2263. PMID: 34097856 78. INSPIRATION Investigators. Effect of Intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: The INSPIRATION randomized clinical trial. JAMA 2021; 325: 1620- 1630. PMID: 33734299 79. REMAP-CAP, ACTIV-4a, ATTACC Investigators. Therapeutic anticoagulation with heparin in critically ill patients with Covid-19. N Engl J Med 2021; 385: 777-789. PMID: 34351722 80. ATTACC, ACTIV-4a, REMAP-CAP Investigators. Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19. N Engl J Med 2021; 385: 790-802. PMID: 34351721 81. Chiang CE, Wang KL, Lip GY. Stroke prevention in atrial fibrillation: an Asian perspective. Thromb Haemost 2014; 111: 789-797. PMID: 24500243 82. 日本静脈学会,肺塞栓症研究会,日本血管外科学会,日本脈管学会,日本循環器学会.新型コロナウイルス感染症(COVID-19)における血栓症予防および抗凝固療法の診療指針(2023年2月25日版 Version 4.1).https://js-phlebology.jp/wp/wp-content/ uploads/2023/03/新型コロナウイルス感染症(COVID-19)における血栓症予防および抗凝固療法の診療指針Ver.4.1(図あり) 20230225.pdf 83. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-1389. PMID: 10227218 84. Laporte S, Mismetti P, Décousus H, et al. RIETE Investigators. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 2008; 117: 1711-1716. PMID: 18347212 85. Yamashita Y, Morimoto T, Kadota K, et al. COMMAND VTE Registry Investigators. Severity of pulmonary embolism at initial diagnosis and long-term clinical outcomes: From the COMMAND VTE Registry. Int J Cardiol 2021; 343: 107-113. PMID: 34499975 86. Poe ND, Dore EK, Swanson LA, et al. Fatal pulmonary embolism. J Nucl Med 1969; 10: 28-33. PMID: 5797555 87. Goldhaber SZ, Morpurgo M. Diagnosis, treatment, and prevention of pulmonary embolism. Report of the WHO/International Society and Federation of Cardiology Task Force. JAMA 1992; 268: 1727- 1733. PMID: 1527883 88. Chartier L, Béra J, Delomez M, et al. Free-floating thrombi in the right heart: diagnosis, management, and prognostic indexes in 38 consecutive patients. Circulation 1999; 99: 2779-2783. PMID: 10351972 89. Giannitsis E, Müller-Bardorff M, Kurowski V, et al. Independent

prognostic value of cardiac troponin T in patients with confirmed